Ultragenyx Pharmaceutical (RARE) Q4 2019 Earnings

5NovConfirmed
Q1 2019
May 19
Q3 2019
Q4 2019
-1.96
-1.87
-1.77
-1.68

Details

Expected EPS
-1.68
Actual EPS
-1.96
Surprise EPS
-0.28
Surprise Percent
+16.67%

Description

Ultragenyx Pharmaceutical (RARE) has reported earnings of -1.96 per share for Q4 2019.

0 Comments

Share your thoughts